Vaccine Adjuvant Nanoformulation Using High Pressure Homogenization Technology
High pressure homogenization is an important technology widely used in the development and scale-up of vaccine adjuvant formulations, including nanoemulsions and liposome-based delivery systems. It enables the production of stable nanoscale dispersions that can significantly enhance immune response and improve overall vaccine efficacy. Key Challenges in Vaccine Adjuvant Formulation Developing effective vaccine adjuvants requires strict control over critical formulation parameters. In particular, particle size must typically be reduced to below 200 nm, while maintaining a narrow particle size distribution (low PDI) and excellent batch-to-batch consistency. However, achieving these requirements using conventional mixing or emulsification methods is often difficult. Many vaccine formulations are also highly sensitive to heat and mechanical stress, which makes process optimization and industrial scale-up from laboratory research to GMP production more complex. Genizer High Pressure Hom...